Helmet mask and tocilizumab for a patient with hemophagocytic lymphohistiocytosis syndrome and COVID-19: a case report
The management of acute hypoxemic respiratory failure and the effect of antiviral drugs in patients with severe COVID-19 have been debated. This case presents the management of a 64-year-old man COVID-19 patient admitted to the Intensive Care Unit with fever, fatigue, shortness of breath and hemopha...
Main Authors: | Ahmet Eroglu, Seyfi Kartal, Ozlem Bayraktar Saral |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Brazilian Journal of Anesthesiology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0104001420302153 |
Similar Items
-
IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome
by: Etienne Dufranc, et al.
Published: (2020-04-01) -
Limited efficacy of tocilizumab in adult patients with secondary hemophagocytic lymphohistiocytosis: a retrospective cohort study
by: Ju Yeon Kim, et al.
Published: (2022-09-01) -
Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report
by: Birgitte Tholin, et al.
Published: (2020-10-01) -
Diagnosis and Management of Adult Malignancy-Associated Hemophagocytic Lymphohistiocytosis
by: Jerry C. Lee, et al.
Published: (2023-03-01) -
Presentations and outcomes of familial hemophagocytic lymphohistiocytosis in the pediatric intensive care units (PICUs)
by: Fahad Alsohime, et al.
Published: (2023-04-01)